261 related articles for article (PubMed ID: 26099473)
1. Use of vessel patterns on contrast-enhanced ultrasonography using a perflubutane-based contrast agent for the differential diagnosis of regenerative nodules from early hepatocellular carcinoma or high-grade dysplastic nodules in patients with chronic liver disease.
Numata K; Fukuda H; Nihonmatsu H; Kondo M; Nozaki A; Chuma M; Morimoto M; Oshima T; Okada M; Murakami T; Takebayashi S; Maeda S; Inayama Y; Nakano M; Tanaka K
Abdom Imaging; 2015 Oct; 40(7):2372-83. PubMed ID: 26099473
[TBL] [Abstract][Full Text] [Related]
2. Contrast-enhanced ultrasound of hepatocarcinogenesis in liver cirrhosis.
Wu W; Chen MH; Sun M; Yan K; Yang W; Li JY
Chin Med J (Engl); 2012 Sep; 125(17):3104-9. PubMed ID: 22932189
[TBL] [Abstract][Full Text] [Related]
3. Central vascular structures as a characteristic finding of regenerative nodules using hepatobiliary phase gadolinium ethoxybenzyl diethylenetriaminepentaacetic acid-enhanced MRI and arterial dominant phase contrast-enhanced US.
Sugimori K; Numata K; Okada M; Nihonmatsu H; Takebayashi S; Maeda S; Nakano M; Tanaka K
J Med Ultrason (2001); 2017 Jan; 44(1):89-100. PubMed ID: 27771842
[TBL] [Abstract][Full Text] [Related]
4. How to characterize non-hypervascular hepatic nodules on contrast-enhanced computed tomography in chronic liver disease: feasibility of contrast-enhanced ultrasound with a microbubble contrast agent.
Yoshizumi H; Maruyama H; Okugawa H; Kobayashi S; Akiike T; Yoshikawa M; Ebara M; Yokosuka O; Matsutani S; Kondo F; Kamiyama N
J Gastroenterol Hepatol; 2008 Oct; 23(10):1528-34. PubMed ID: 17944882
[TBL] [Abstract][Full Text] [Related]
5. Contrast-enhanced Doppler ultrasonography in the diagnosis of hepatocellular carcinoma and premalignant lesions in patients with cirrhosis.
Fracanzani AL; Burdick L; Borzio M; Roncalli M; Bonelli N; Borzio F; Maraschi A; Fiorelli G; Fargion S
Hepatology; 2001 Dec; 34(6):1109-12. PubMed ID: 11731999
[TBL] [Abstract][Full Text] [Related]
6. Depiction of portal supply in early hepatocellular carcinoma and dysplastic nodule: value of pure arterial ultrasound imaging in hepatocellular carcinoma.
Kudo M; Hatanaka K; Inoue T; Maekawa K
Oncology; 2010 Jul; 78 Suppl 1():60-7. PubMed ID: 20616586
[TBL] [Abstract][Full Text] [Related]
7. Clinical utility of sequential imaging of hepatocellular carcinoma by contrast-enhanced power Doppler ultrasonograpy.
Suzuki Y; Fujimoto Y; Hosoki Y; Suzuki M; Sakurai S; Ohhira M; Saito H; Kohgo Y
Eur J Radiol; 2003 Nov; 48(2):214-9. PubMed ID: 14680917
[TBL] [Abstract][Full Text] [Related]
8. Differential patterns of contrast enhancement in different focal liver lesions after injection of the microbubble US contrast agent SonoVue.
Quaia E; Degobbis F; Tona G; Mosconi E; Bertolotto M; Pozzi Mucelli R
Radiol Med; 2004 Mar; 107(3):155-65. PubMed ID: 15031681
[TBL] [Abstract][Full Text] [Related]
9. Small nodules (1-2 cm) in liver cirrhosis: characterization with contrast-enhanced ultrasound.
Jang HJ; Kim TK; Wilson SR
Eur J Radiol; 2009 Dec; 72(3):418-24. PubMed ID: 18834687
[TBL] [Abstract][Full Text] [Related]
10. Contrast-enhanced ultrasound for characterisation of hepatic lesions appearing non-hypervascular on CT in chronic liver diseases.
Maruyama H; Takahashi M; Ishibashi H; Yoshikawa M; Yokosuka O
Br J Radiol; 2012 Apr; 85(1012):351-7. PubMed ID: 21224305
[TBL] [Abstract][Full Text] [Related]
11. Use of contrast-enhanced ultrasonography with a perflubutane-based contrast agent performed one day after transarterial chemoembolization for the early assessment of residual viable hepatocellular carcinoma.
Takizawa K; Numata K; Morimoto M; Kondo M; Nozaki A; Moriya S; Ishii T; Oshima T; Fukuda H; Okada M; Takebayashi S; Maeda S; Tanaka K
Eur J Radiol; 2013 Sep; 82(9):1471-80. PubMed ID: 23769188
[TBL] [Abstract][Full Text] [Related]
12. Characterization of hepatic lesions (≤ 30 mm) with liver-specific contrast agents: a comparison between ultrasound and magnetic resonance imaging.
Takahashi M; Maruyama H; Shimada T; Kamezaki H; Sekimoto T; Kanai F; Yokosuka O
Eur J Radiol; 2013 Jan; 82(1):75-84. PubMed ID: 23116806
[TBL] [Abstract][Full Text] [Related]
13. [Characterization of focal liver lesions with contrast-enhanced low MI real time ultrasound and SonoVue].
Hohmann J; Skrok J; Puls R; Albrecht T
Rofo; 2003 Jun; 175(6):835-43. PubMed ID: 12811698
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis of hepatocellular carcinoma nodules in patients with chronic liver disease using contrast-enhanced sonography: usefulness of the combination of arterial- and kupffer-phase enhancement patterns.
Suzuki K; Okuda Y; Ota M; Kojima F; Horimoto M
J Ultrasound Med; 2015 Mar; 34(3):423-33. PubMed ID: 25715363
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of posttreatment response of hepatocellular carcinoma with contrast-enhanced coded phase-inversion harmonic US: comparison with dynamic CT.
Ding H; Kudo M; Onda H; Suetomi Y; Minami Y; Chung H; Kawasaki T; Maekawa K
Radiology; 2001 Dec; 221(3):721-30. PubMed ID: 11719668
[TBL] [Abstract][Full Text] [Related]
16. Hepatocellular nodules in liver cirrhosis: contrast-enhanced ultrasound.
Kim TK; Lee KH; Khalili K; Jang HJ
Abdom Imaging; 2011 Jun; 36(3):244-63. PubMed ID: 21253723
[TBL] [Abstract][Full Text] [Related]
17. Utility of Contrast-enhanced Ultrasonography with Perflubutane for Determining Histologic Grade in Hepatocellular Carcinoma.
Tada T; Kumada T; Toyoda H; Ito T; Sone Y; Kaneoka Y; Maeda A; Okuda S; Otobe K; Takahashi K
Ultrasound Med Biol; 2015 Dec; 41(12):3070-8. PubMed ID: 26360976
[TBL] [Abstract][Full Text] [Related]
18. Imaging features of subcentimeter hypointense nodules on gadoxetic acid-enhanced hepatobiliary phase MR imaging that progress to hypervascular hepatocellular carcinoma in patients with chronic liver disease.
Jang KM; Kim SH; Kim YK; Choi D
Acta Radiol; 2015 May; 56(5):526-35. PubMed ID: 24838304
[TBL] [Abstract][Full Text] [Related]
19. Accuracy and disagreement of computed tomography and magnetic resonance imaging for the diagnosis of small hepatocellular carcinoma and dysplastic nodules: role of biopsy.
Sersté T; Barrau V; Ozenne V; Vullierme MP; Bedossa P; Farges O; Valla DC; Vilgrain V; Paradis V; Degos F
Hepatology; 2012 Mar; 55(3):800-6. PubMed ID: 22006503
[TBL] [Abstract][Full Text] [Related]
20. Changes in tumor vascularity precede microbubble contrast accumulation deficit in the process of dedifferentiation of hepatocellular carcinoma.
Maruyama H; Takahashi M; Ishibashi H; Okabe S; Yoshikawa M; Yokosuka O
Eur J Radiol; 2010 Jul; 75(1):e102-6. PubMed ID: 19783392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
